Global Sustained Release Excipients Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Sustained Release Excipients Market Research Report 2024
This report mainly focuses on sustained release excipients market. These medications prolong the medication's release from a tablet or capsule so that you'll get the medication's benefits over a longer period of time.
According to Mr Accuracy reports new survey, global Sustained Release Excipients market is projected to reach US$ 1504.1 million in 2029, increasing from US$ 1069 million in 2022, with the CAGR of 5.0% during the period of 2024 to 2029.
Factors for market growth include increasing benefits over traditional dosage forms and antibiotic resistance. One of the major challenges pharmaceutical marketers face is patient compliance. When a drug needs to be taken multiple times a day, patient acceptance of the drug can be greatly reduced, with the risk of suboptimal treatment outcomes. In such cases, the standard solution to improve drug acceptance is to formulate the drug in a dosage form that releases the active ingredient stably over an extended period of time. The sustained-release profile allows for customized dosing of the active ingredient over an extended period of time, up to 24 hours. Common approaches to achieve this release rate are through the use of film coatings, ER matrices, or ER-loaded granules. This extended-release formulation has gained considerable attention in the pharmaceutical industry and is expected to continue to be an important tool in improving the patient experience with existing and new drugs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Sustained Release Excipients market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
BASF
Ashland
Roquette Freres
Colorcon
Croda Health Care
Dow
DuPont
Segment by Type
Gelatin
Polymers
Minerals
Sugars
Alcohol
Chitosan
Pharmaceutical Companies
Biopharmaceutical Companies
Nutraceutical Manufacturers
Contract Manufacturing Organizations
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Sustained Release Excipients report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports new survey, global Sustained Release Excipients market is projected to reach US$ 1504.1 million in 2029, increasing from US$ 1069 million in 2022, with the CAGR of 5.0% during the period of 2024 to 2029.
Factors for market growth include increasing benefits over traditional dosage forms and antibiotic resistance. One of the major challenges pharmaceutical marketers face is patient compliance. When a drug needs to be taken multiple times a day, patient acceptance of the drug can be greatly reduced, with the risk of suboptimal treatment outcomes. In such cases, the standard solution to improve drug acceptance is to formulate the drug in a dosage form that releases the active ingredient stably over an extended period of time. The sustained-release profile allows for customized dosing of the active ingredient over an extended period of time, up to 24 hours. Common approaches to achieve this release rate are through the use of film coatings, ER matrices, or ER-loaded granules. This extended-release formulation has gained considerable attention in the pharmaceutical industry and is expected to continue to be an important tool in improving the patient experience with existing and new drugs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Sustained Release Excipients market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
BASF
Ashland
Roquette Freres
Colorcon
Croda Health Care
Dow
DuPont
Segment by Type
Gelatin
Polymers
Minerals
Sugars
Alcohol
Chitosan
Segment by Application
Pharmaceutical Companies
Biopharmaceutical Companies
Nutraceutical Manufacturers
Contract Manufacturing Organizations
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Sustained Release Excipients report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source